Cargando…
β-Cell Expansion for Therapeutic Compensation of Insulin Resistance in Type 2 Diabetes
Insulin resistance is the primary cause of type 2 diabetes. However, if compensated by increased insulin production, insulin resistance by itself does not lead to overt disease. Type 2 diabetes develops when this compensation is insufficient, due to defects in β-cell function and in regulation of th...
Autor principal: | Efrat, Shimon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480502/ https://www.ncbi.nlm.nih.gov/pubmed/12745664 http://dx.doi.org/10.1080/15438600303731 |
Ejemplares similares
-
Metformin Preserves β-Cell Compensation in Insulin Secretion and Mass Expansion in Prediabetic Nile Rats
por: Huang, Hui, et al.
Publicado: (2021) -
Growth Factor-Dependent Proliferation of the Pancreatic β-cell Line βTC-tet: An Assay for β-cell Mitogenic Factors
por: Milo-Landesman, Dalit, et al.
Publicado: (2002) -
TGFβ Pathway Inhibition Redifferentiates Human Pancreatic Islet β Cells Expanded In Vitro
por: Toren-Haritan, Ginat, et al.
Publicado: (2015) -
Epigenetic Memory: Lessons From iPS Cells Derived From Human β Cells
por: Efrat, Shimon
Publicado: (2021) -
EP3 signaling is decoupled from the regulation of glucose-stimulated insulin secretion in β-cells compensating for obesity and insulin resistance
por: Schaid, Michael D., et al.
Publicado: (2023)